Bladder Cancer
Showing NaN - NaN of 53
Bladder Cancer Trial in Baltimore (ERAS Protocol, Standard of Care)
Not yet recruiting
- Bladder Cancer
- ERAS Protocol
- Standard of Care
-
Baltimore, MarylandJohns Hopkins Hospital
Jun 14, 2023
Bladder Cancer Trial in Washington, Baltimore (Prostate capsule-sparing radical cystectomy, Nerve sparing radical cystectomy)
Not yet recruiting
- Bladder Cancer
- Prostate capsule-sparing radical cystectomy
- Nerve sparing radical cystectomy
-
Washington, District of Columbia
- +1 more
Mar 28, 2023
Gender Related Coping and Survivorship for Genitourinary Cancers
Recruiting
- Bladder Cancer
- Additional Education
- +2 more
-
Washington, District of Columbia
- +1 more
Jan 23, 2023
Breast Cancer, Prostate Cancer, Melanoma (Skin) Trial in Baltimore (Written Weight Loss Material, Weight Loss App, Behavioral
Active, not recruiting
- Breast Cancer
- +7 more
- Written Weight Loss Material
- +2 more
-
Baltimore, MarylandJohns Hopkins ProHealth
Jan 19, 2023
Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Durvalumab (Cohort 1-3)
- +7 more
-
Phoenix, Arizona
- +10 more
Jan 11, 2023
High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab
Not yet recruiting
- High Grade Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Washington, District of Columbia
- +1 more
Jan 5, 2023
NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)
Recruiting
- Non-small Cell Lung Cancer
- +11 more
-
Birmingham, Alabama
- +32 more
Jan 4, 2023
Intravesical Therapy and Surgery as Treatment Options for
Recruiting
- Bladder Cancer
- +2 more
-
Birmingham, Alabama
- +37 more
Nov 28, 2022
Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)
Completed
- Urothelial Carcinoma
- Bladder Cancer
- Placebo
- Pembrolizumab
-
Phoenix, Arizona
- +27 more
Sep 16, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)
Active, not recruiting
- Metastatic Cancer
- +9 more
-
Mobile, Alabama
- +19 more
Aug 1, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,
Active, not recruiting
- Bladder Cancer
- therapeutic conventional surgery
- +2 more
-
Los Angeles, California
- +34 more
Jul 20, 2022
Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)
Completed
- Bladder Cancer
- Urothelial Carcinoma
-
Birmingham, Alabama
- +34 more
Jul 7, 2022
Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore
Recruiting
- Small Cell Neuroendocrine Carcinoma of Bladder
- +2 more
- Atezolizumab
- +4 more
-
Washington, District of Columbia
- +1 more
Jun 27, 2022
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)
Completed
- Bladder Cancer
- induction cisplatin
- +13 more
-
Atlanta, Georgia
- +10 more
May 23, 2022
Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)
Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)
Active, not recruiting
- Bladder Cancer
- +3 more
- IPI-549 (eganelisib)
- +2 more
-
Fort Wayne, Indiana
- +28 more
Apr 1, 2022
Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Biospecimen Collection
-
Los Angeles, California
- +7 more
Feb 14, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022